MindOmics
ML-based Platform for Diagnosing Mental Illnesses
Health Tech & Life Sciences
Private
Company Overview
Snapshot
Founded in December 2022 by Ben-Zion Haddad and Uri Bertocchi, MindOmics operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on the development of its core technology.
Business overview
MindOmics is a Health Tech & Life Sciences company developing a SaaS platform that leverages advanced machine learning algorithms for the accurate diagnosis of mental illnesses. The platform integrates diverse data types to provide comprehensive diagnostic insights, addressing the critical issue of misdiagnosis within the healthcare industry. MindOmics operates within the Digital Healthcare and Digital Medical Diagnostics sectors, targeting healthcare providers.
Company Intelligence Q&A
- What is MindOmics' primary focus?
- MindOmics focuses on developing a SaaS platform that utilizes machine learning algorithms to accurately diagnose mental illnesses, aiming to reduce misdiagnoses in the healthcare industry.
- Who are the founders of MindOmics?
- MindOmics was co-founded by Ben-Zion Haddad, who serves as CEO, and Uri Bertocchi, the CTO.
- When was MindOmics founded?
- MindOmics was founded in December 2022.
- What technology does MindOmics utilize?
- MindOmics' platform is built on advanced machine learning algorithms and artificial intelligence to process diverse data types for diagnostic purposes.
- In which sector does MindOmics primarily operate?
- MindOmics operates primarily in the Health Tech & Life Sciences sector, specifically within Digital Healthcare and Digital Medical Diagnostics.